WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001026627) LIPOSOME ENCAPSULATED SILVER SALT COMPOSITIONS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/026627    International Application No.:    PCT/CA2000/001199
Publication Date: 19.04.2001 International Filing Date: 13.10.2000
Chapter 2 Demand Filed:    29.03.2001    
IPC:
A61K 9/127 (2006.01), A61K 31/355 (2006.01), A61K 31/635 (2006.01), A61K 33/38 (2006.01)
Applicants: 1170535 ONTARIO INC. [CA/CA]; Suite 3000, Royal Bank Plaza, South Tower, 200 Bay Street, Toronto, Ontario M5J 2J1 (CA) (For All Designated States Except US).
DICOSMO, Frank [CA/CA]; (CA) (For US Only).
BURROWS, Lori [CA/CA]; (CA) (For US Only).
DITIZIO, Valerio [CA/CA]; (CA) (For US Only)
Inventors: DICOSMO, Frank; (CA).
BURROWS, Lori; (CA).
DITIZIO, Valerio; (CA)
Agent: BARTOSZEWICZ, Lola, A.; Sim & McBurney, 330 Univeristy Avenue, 6th Floor, Toronto, Ontario M5G 1R7 (CA)
Priority Data:
60/159,427 14.10.1999 US
Title (EN) LIPOSOME ENCAPSULATED SILVER SALT COMPOSITIONS
(FR) COMPOSITIONS DE SELS D'ARGENT ENCAPSULEES DANS UN LIPOSOME
Abstract: front page image
(EN)The invention provides encapsulated compositions of silver salts for the treatment of infection at surface and internal wounds and other sites prone to bacterial and fungal infection. The compositions comprise liposome encapsulated silver lactate or other suitable silver salts in a pharmaceutically acceptable carrier.
(FR)L'invention concerne des compositions encapsulées de sels d'argent destinées au traitement d'infections de surface et de plaies profondes et d'autres régions sujettes aux infections bactériennes et fongiques. Les compositions renferment un lactate d'argent encapsulé dans un liposome ou d'autres sels d'argent adéquats dans un excipient pharmaceutiquement acceptable.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)